Literature DB >> 12792501

Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France.

Camille Taillé1, Jacques Cadranel, Agnès Bellocq, Gabriel Thabut, Olivier Soubrane, François Durand, Philippe Ichaï, Christophe Duvoux, Jacques Belghiti, Yvon Calmus, Hervé Mal.   

Abstract

BACKGROUND: Although the possibility of reversing hepatopulmonary syndrome (HPS) after liver transplantation is now well established, the proportion of patients in whom reversibility is observed and the time to resolution of HPS remain uncertain.
METHODS: We analyzed the outcome of all adult patients with HPS who underwent orthotopic liver transplantation in all the liver transplant centers in Paris, during a 10-year period.
RESULTS: Twenty-three adult patients (median age, 47 years; range, 14-64) underwent transplantation in four institutions. Median PaO(2) was 52 (range, 32-67) mm Hg and median alveolar-arterial oxygen gradient was 66 mm Hg. When patients were breathing 100% O(2), median PaO(2) was 310 (range, 74-663) mm Hg. Median isotopic shunt ratio was 33% (range, 0-80%). The overall mortality during the study period was 30.5% (7/23). Perioperative mortality was 8.5%, whereas late mortality was 22%. None of the preoperative characteristics of HPS (isotopic shunt ratio, PaO(2) on room air or on 100% oxygen) was associated with overall postoperative mortality. Of the 21 patients surviving the perioperative period (median follow-up, 17 months; range, 0.5-72), a decrease in alveolar-arterial oxygen gradient of at least 5 mm Hg and at least 10 mm Hg was observed in 21 of 21 and in 18 of 21 patients, respectively, with great variations in the time of improvement. The threshold of 70 mm Hg was reached in 15 patients. The lower the preoperative PaO(2), the longer the time to reach this point.
CONCLUSION: Our data strongly support the role of orthotopic liver transplantation in adult patients with HPS, regardless of its severity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12792501     DOI: 10.1097/01.TP.0000061612.78954.6C

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  17 in total

1.  Interstitial lung disease in patients with hepatopulmonary syndrome: a case series and new observations.

Authors:  S Shahangian; M Y Shino; I Barjaktarevic; I Susanto; J A Belperio; M C Fishbein; T Wang
Journal:  Lung       Date:  2014-03-30       Impact factor: 2.584

Review 2.  Hepatopulmonary syndrome: What we know and what we would like to know.

Authors:  Israel Grilo-Bensusan; Juan Manuel Pascasio-Acevedo
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 3.  Differential diagnosis of hepatopulmonary syndrome (HPS): Portopulmonary hypertension (PPH) and hereditary hemorrhagic telangiectasia (HHT).

Authors:  Inna Krynytska; Mariya Marushchak; Anna Mikolenko; Anzhela Bob; Iryna Smachylo; Ludmyla Radetska; Olga Sopel
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

Review 4.  Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease.

Authors:  Michael J Krowka
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

5.  Reversal of severe hepatopulmonary syndrome in chronic hepatic cirrhosis by living donor liver transplantation: report of two cases.

Authors:  Kefei Chen; Bo Li
Journal:  Surg Today       Date:  2011-03-02       Impact factor: 2.549

6.  Pediatric living donor liver transplantation for biliary atresia with hepatopulmonary syndrome: the gift of a second wind.

Authors:  Taizen Urahashi; Koichi Mizuta; Yukihiro Sanada; Minoru Umehara; Taiichi Wakiya; Shuji Hishikawa; Masanobu Hyodo; Yasunaru Sakuma; Takehito Fujiwara; Yoshikazu Yasuda; Hideo Kawarasaki
Journal:  Pediatr Surg Int       Date:  2011-02-18       Impact factor: 1.827

Review 7.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

Review 8.  Pulmonary vascular complications of liver disease.

Authors:  Jason S Fritz; Michael B Fallon; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2012-11-15       Impact factor: 21.405

9.  Hepatopulmonary syndrome: use of extracorporeal life support for life-threatening hypoxia following liver transplantation.

Authors:  Geoffrey M Fleming; Timothy T Cornell; Theodore H Welling; John C Magee; Gail M Annich
Journal:  Liver Transpl       Date:  2008-07       Impact factor: 5.799

10.  Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study.

Authors:  A Morvan; M Gazon; S Duperret; Z Schmitt; P Pradat; K Mohkam; F Aubrun
Journal:  Int J Organ Transplant Med       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.